Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia

被引：0
|
作者：
Hiroyuki Hashimoto
Masato Takeuchi
Koji Kawakami
机构：
[1] Kyoto University,Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Allopurinol; Cardiovascular risk; Epidemiology; Febuxostat; Gout; Hyperuricemia; Xanthine oxidase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3075 / 3082
页数：7
相关论文
共 50 条
  • [1] Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia
    Hashimoto, Hiroyuki
    Takeuchi, Masato
    Kawakami, Koji
    CLINICAL RHEUMATOLOGY, 2023, 42 (11) : 3075 - 3082
  • [2] Impact of Hyperuricemia and Urate-Lowering Agents on Cardiovascular Diseases
    Sosa, Franklin
    Shaban, Mohammed
    Lopez, Jose
    Duarte, Gustavo J.
    Jain, Swati
    Khizar, Asma
    Vittorio, Timothy
    Mishra, Rishabh
    Guerra, Miguel Rodriguez
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2024, 18
  • [3] Association between urate-lowering therapy initiation and all-cause mortality in patients with type 2 diabetes and asymptomatic hyperuricemia
    Chen, Ruixuan
    Nie, Sheng
    Zhou, Shiyu
    Su, Licong
    Li, Yanqin
    Zhang, Xiaodong
    Luo, Fan
    Xu, Ruqi
    Gao, Qi
    Lin, Yuxin
    Guo, Zhixin
    Cao, Lisha
    Xu, Xin
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (06)
  • [4] Cardiovascular outcomes of urate-lowering therapies in patients with gout or hyperuricemia: a network meta-analysis
    Yan, Yilong
    Bai, Ying
    Wang, Jiawei
    Li, Guangyao
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [5] Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution
    Stamp, Lisa
    Dalbeth, Nicola
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (04) : 457 - 464
  • [6] Increasing trend of asymptomatic hyperuricemia under treatment with urate-lowering drugs in Japan
    Hakodaa, Masayuki
    Kasagi, Fumiyoshi
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 880 - 884
  • [7] Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis
    Zhao Li
    Cao Ling
    Zhao Tian-Yi
    Yang Xue
    Zhu Xiao-Xia
    Zou He-Jian
    Wan Wei-Guo
    Xue Yu
    中华医学杂志英文版, 2020, 133 (08) : 982 - 993
  • [8] Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis
    Zhao, Li
    Cao, Ling
    Zhao, Tian-Yi
    Yang, Xue
    Zhu, Xiao-Xia
    Zou, He-Jian
    Wan, Wei-Guo
    Xue, Yu
    CHINESE MEDICAL JOURNAL, 2020, 133 (08) : 982 - 993
  • [9] Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy
    Lee, Tao Han
    Chen, Jia-Jin
    Wu, Chao-Yi
    Yang, Chih-Wei
    Yang, Huang-Yu
    DIAGNOSTICS, 2021, 11 (09)
  • [10] Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
    Honda, Masataka
    Horiuchi, Hideki
    Torii, Tomoko
    Nakajima, Akihiro
    Iijima, Takeshi
    Murano, Hiroshi
    Yamanaka, Hisashi
    Ito, Shuichi
    BMC PEDIATRICS, 2021, 21 (01)
12345